Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Epilepsy Behav. 2021 Apr 8;118:107943. doi: 10.1016/j.yebeh.2021.107943

Table 3.

Anxiety and depression screening sensitivity, specificity & 95% CI estimates by instrument (n=422)

Instrument, positive values
(reference)
AUC Sensitivity Sensitivity 95% CI* Specificity Specificity 95% CI*
GAD-2, > 2
(GAD-7, ≥ 10)
0.98 0.95 0.89–0.98 0.90 0.86–0.93
GAD-SI, ≥ 2
(GAD-7, ≥ 10)
0.89 0.72 0.62–0.80 0.93 0.90–0.95
NDDIE-2, > 4
(NDDI-E, ≥ 16)
0.96 0.78 0.68–0.85 0.95 0.92–0.97
NDDIE-2, >3
(NDDI-E, ≥ 16)
0.96 1.0 0.96–1.0 0.80 0.76–0.84
PHQ-2, >0
(NDDI-E, ≥ 16)
0.50 0.0 0.0–0.043 1.0 0.98–1.0

Confidence interval, CI; Generalized Anxiety Disorder −7, GAD-7; Generalized Anxiety Disorder-2, GAD-2; Single-item GAD, GAD-SI; Neurological Disorders Depression Inventory-Epilepsy, NDDI-E; Neurological Disorders Depression Inventory Epilepsy-2, NDDIE-2

*

Confidence intervals are calculated on the basis of inverting the score test for a binomial proportion.